IBRX - Lifshitz Law PLLC Announces Investigations of Arrow Financial Corp. (NASDAQ: AROW) ImmunityBio Inc. (NASDAQ: IBRX) BioXcel Therapeutics Inc. (NASDAQ: BTAI) and Baxter International Inc. (NYSE: BAX) | Benzinga

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) --

Arrow Financial Corp. (NASDAQ:AROW)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) Arrow maintained defective disclosure controls and procedures and internal controls over financial reporting; (ii) the foregoing increased the risk that the Company could not timely file one or more of its periodic financial reports with the SEC as required by the NASDAQ's listing requirements; (iii) accordingly, Arrow was at an increased risk of being delisted from the NASDAQ; (iv) following the disclosure of deficiencies in the Company's disclosure controls and procedures and internal controls over financial reporting, Arrow downplayed the severity of these issues and the associated risks; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are an AROW investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ImmunityBio, Inc. (NASDAQ:IBRX)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) ImmunityBio ...

IBRX), BioXcel Therapeutics, Inc. (NASDAQ: BTAI), and Baxter International Inc. (NYSE: BAX)>Full story available on Benzinga.com